Antidiabetics Market growth outlook with industry review and forecasts

1
Antidiabetics Market to surpass 110Bn by 2024
Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Antidiabetics Market

• U.S. antidiabetics market size valued over USD
  19.4 billion in 2016 and expected to grow
  significantly over the coming years. Increased
  healthcare expenditure along with availability of
  improved healthcare infrastructure and favorable
  reimbursement policies should drive antidiabetics
  market size.
• UK contributed for significant revenue share in
  2016. The growth is attributed due to wide range
  of funds offered by Diabetes UK for research
  related to the treatment of diabetes and its
  complications. In November 2016, the Prime
  Minister introduced new Diabetes UK office on
  World Diabetes Day.
• Japan antidiabetics market should grow at
  significant rate over the forecast period.
  Diabetic population is on rise due to lifestyle
  changes that will accompany economic growth and
  drive antidiabetic market growth. The Japan
  Diabetes Society (JDS) encourage progress and
  development of diabetes study and prevent people
  from disease in the country.

3
Continued...

• Brazil contributed for significant revenue share.
  The growth is attributed due to early adoption of
  insulin analogues and increased use of these
  products in the country.
• Some of the companies operating in antidiabetics
  market include Eli Lilly, Pfizer, Novo Nordisk,
  Takeda Pharmaceuticals, Sanofi Aventis, Merck,
  Boehringer Ingelheim and Oramed Pharmaceuticals.
• Advent of new technologies in products like long
  acting insulin analogs as well as rapid acting
  with increased effectiveness should drive
  industry growth over the forecast timeframe. The
  novel insulin pen technology permits low-pain and
  suitable daily insulin injection that should
  upsurge therapy sales. Type 2 diabetes mellitus
  (T2DM) has strong familial aggregation, the
  person with a parent or sibling with disease are
  at high risk. People with obesity, hypertension,
  or dyslipidemia and women with history of
  gestational diabetes are also at high risk to
  develop T2DM.

4
India Antidiabetics Market, By Product, 2013 -
2024 (USD Million)

5

Browse Full Market Research Report On
Antidiabetics Market _at_ https//goo.gl/4Lig62 Requ
est for a Sample of this Research Report
_at_ https//www.gminsights.com/request-sample/detail
/504
6
360 Analysis

• Application Trends
• Type II diabetes market was leading the revenue
  share in 2016 and should show a similar trend
  over the forecast years. Presence of large
  patient pool suffering from type II diabetes
  owing to adoption of lifestyle changes coupled
  with increased resistance to insulin will boost
  demand for antidiabetic drugs in the future. Type
  I diabetes will hold a smaller share as compared
  to the former but is expected to witness
  significant growth rate during the forecast
  timeframe.
• Regional Trends
• U.S. antidiabetics market accounted for largest
  regional share in 2016 owing to high prevalence
  of diabetes in the country. Rising geriatric
  population, adoption of sedentary lifestyle,
  increasing cases of obesity, lack of physical
  activity are the major risk factors for the
  increasing diabetes prevalence contributing to
  rise in demand for insulin and other
  anti-diabetic products over the coming few years.
• Competitive Market Share
• Some of the major players dominating global
  antidiabetics market are Novo Nordisk, Eli Lilly
  and Sanofi. Extensive product portfolio and
  rising RD investment for producing innovative
  and pipeline products are the major strategies
  adopted by these players to maintain their market
  share. Other active players in the market include
  Takeda Pharmaceuticals, Merck, Boehringer
  Ingelheim and Bristol-Myers Squibb.

7
Stay In Touch Website www.gminsights.com Soci
al Media